![Blood Journal on X: "An epitope-based approach of HLA-matched platelets for transfusion: a noninferiority crossover randomized trial https://t.co/h4qWigIlqO https://t.co/H0PyEvSYLp" / X Blood Journal on X: "An epitope-based approach of HLA-matched platelets for transfusion: a noninferiority crossover randomized trial https://t.co/h4qWigIlqO https://t.co/H0PyEvSYLp" / X](https://pbs.twimg.com/media/EsXCszhXIAEKPIy.jpg:large)
Blood Journal on X: "An epitope-based approach of HLA-matched platelets for transfusion: a noninferiority crossover randomized trial https://t.co/h4qWigIlqO https://t.co/H0PyEvSYLp" / X
![iPSC-Derived Platelets Depleted of HLA Class I Are Inert to Anti-HLA Class I and Natural Killer Cell Immunity - ScienceDirect iPSC-Derived Platelets Depleted of HLA Class I Are Inert to Anti-HLA Class I and Natural Killer Cell Immunity - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S221367111930414X-fx1.jpg)
iPSC-Derived Platelets Depleted of HLA Class I Are Inert to Anti-HLA Class I and Natural Killer Cell Immunity - ScienceDirect
![An epitope-based approach of HLA-matched platelets for transfusion: a noninferiority crossover randomized trial - ScienceDirect An epitope-based approach of HLA-matched platelets for transfusion: a noninferiority crossover randomized trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497121000823-grabsf1.jpg)
An epitope-based approach of HLA-matched platelets for transfusion: a noninferiority crossover randomized trial - ScienceDirect
Anti-HLA antibodies with complementary and synergistic interaction geometries promote classical complement activation on platelets | Haematologica
![Frontiers | Anti-HLA Class I alloantibodies in platelet transfusion refractoriness: From mechanisms and determinants to therapeutic prospects Frontiers | Anti-HLA Class I alloantibodies in platelet transfusion refractoriness: From mechanisms and determinants to therapeutic prospects](https://www.frontiersin.org/files/Articles/1125367/fimmu-14-1125367-HTML/image_m/fimmu-14-1125367-g001.jpg)
Frontiers | Anti-HLA Class I alloantibodies in platelet transfusion refractoriness: From mechanisms and determinants to therapeutic prospects
Development and performance characteristics of Platelet Virtual Crossmatch (<fc>PLT VXM</fc>), a software applicatio
![Clinical relevance of the HLA system in blood transfusion - Brown - 2011 - Vox Sanguinis - Wiley Online Library Clinical relevance of the HLA system in blood transfusion - Brown - 2011 - Vox Sanguinis - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/0ffbe335-4079-41de-9124-38f6ccf4bff3/vox_1474_f1.gif)